[{"address1": "80 Guest Street", "address2": "Suite 601", "city": "Boston", "state": "MA", "zip": "02135", "country": "United States", "phone": "617 500 8099", "website": "https://www.compasstherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States. The company's lead product candidates include CTX-009, a bispecific antibody that blocks Delta-like ligand 4 a ligand of Notch-1, and vascular endothelial growth factor A signaling pathways, which are critical to angiogenesis and tumor vascularization; and CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137, a key co-stimulatory receptor on immune cells. It also develops CTX-8371, a bispecific inhibitor that targets PD-1 and PD-L1 checkpoint inhibitor antibodies. The company was founded in 2014 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 32, "companyOfficers": [{"maxAge": 1, "name": "Dr. Thomas J. Schuetz M.D., Ph.D.", "age": 63, "title": "Chief Executive Officer", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 835875, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Vered  Bisker-Leib MBA, Ph.D.", "age": 53, "title": "Advisor", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 719000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Barry  Shin J.D.", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jonathan  Anderman J.D.", "title": "Senior Vice President, General Counsel & Corporate Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Anna  Gifford", "title": "Communications Manager", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Minori  Rosales M.D., Ph.D.", "age": 61, "title": "Senior VP & Head of Clinical Development", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Karin  Herrera B.A.", "title": "VP & Head of Clinical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James  Kranz Ph.D.", "title": "VP and Head of Chemistry Manufacturing & Controls", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.08, "open": 3.1, "dayLow": 2.8501, "dayHigh": 3.2, "regularMarketPreviousClose": 3.08, "regularMarketOpen": 3.1, "regularMarketDayLow": 2.8501, "regularMarketDayHigh": 3.2, "payoutRatio": 0.0, "beta": 0.976, "forwardPE": -5.6764708, "volume": 957416, "regularMarketVolume": 957416, "averageVolume": 1388162, "averageVolume10days": 1217100, "averageDailyVolume10Day": 1217100, "bid": 2.29, "ask": 3.6, "bidSize": 2, "askSize": 20, "marketCap": 398320128, "fiftyTwoWeekLow": 0.765, "fiftyTwoWeekHigh": 4.08, "priceToSalesTrailing12Months": 468.6119, "fiftyDayAverage": 2.3526, "twoHundredDayAverage": 1.65769, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 295249632, "profitMargins": 0.0, "floatShares": 82933249, "sharesOutstanding": 137588992, "sharesShort": 2748956, "sharesShortPriorMonth": 2210789, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.02, "heldPercentInsiders": 0.18168, "heldPercentInstitutions": 0.71294, "shortRatio": 1.02, "shortPercentOfFloat": 0.028199999, "impliedSharesOutstanding": 137588992, "bookValue": 1.006, "priceToBook": 2.8777335, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -47757000, "trailingEps": -0.35, "forwardEps": -0.51, "enterpriseToRevenue": 347.353, "enterpriseToEbitda": -5.384, "52WeekChange": 0.72067034, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 2.895, "targetHighPrice": 32.0, "targetLowPrice": 4.0, "targetMeanPrice": 11.22222, "targetMedianPrice": 10.0, "recommendationMean": 1.55556, "recommendationKey": "buy", "numberOfAnalystOpinions": 9, "totalCash": 135402000, "totalCashPerShare": 0.984, "ebitda": -54834000, "totalDebt": 6877000, "quickRatio": 30.544, "currentRatio": 31.838, "totalRevenue": 850000, "debtToEquity": 4.969, "revenuePerShare": 0.006, "returnOnAssets": -0.21712999, "returnOnEquity": -0.32004002, "grossProfits": 850000, "freeCashflow": -31852500, "operatingCashflow": -48047000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -65.22824, "financialCurrency": "USD", "symbol": "CMPX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NCM", "messageBoardId": "finmb_266166780", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -6.0064917, "regularMarketPrice": 2.895, "marketState": "REGULAR", "corporateActions": [], "regularMarketTime": 1740170314, "firstTradeDateMilliseconds": 1617629400000, "shortName": "Compass Therapeutics, Inc.", "longName": "Compass Therapeutics, Inc.", "hasPrePostMarketData": true, "regularMarketChange": -0.18499994, "regularMarketDayRange": "2.8501 - 3.2", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1388162, "fiftyTwoWeekLowChange": 2.13, "fiftyTwoWeekLowChangePercent": 2.784314, "fiftyTwoWeekRange": "0.765 - 4.08", "fiftyTwoWeekHighChange": -1.185, "fiftyTwoWeekHighChangePercent": -0.29044116, "fiftyTwoWeekChangePercent": 72.06703, "epsTrailingTwelveMonths": -0.35, "epsForward": -0.51, "epsCurrentYear": -0.33875, "priceEpsCurrentYear": -8.546125, "fiftyDayAverageChange": 0.5423999, "fiftyDayAverageChangePercent": 0.23055337, "twoHundredDayAverageChange": 1.2373099, "twoHundredDayAverageChangePercent": 0.7464061, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-11-02", "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "displayName": "Compass Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]